Using new guidelines would increase diabetes screening eligibility

According to a research paper published in the May 17 edition of The Advocate, the U.S. Preventive Services Task Force’s (USPSTF), and American Diabetes Association’s (ADA) diabetes screening guidelines, the new changes would increase screening eligibility among U.S. adult screening candidates. Journal of the American Medical Association.

Michael Fang, Ph.D., of the Johns Hopkins Bloomberg School of Public Health Baltimore used data from the 2015-2020 National Health and Nutrition Examination Survey Survey in order to estimate the proportion of asymptomatic U.S. adults that are eligible for screening based ADA and USPSTF guidelines.

For 4,480 adults, data were included. The researchers found an increase in the weighted eligibility for screening from 36.3 to 42.0 percent when comparing USPSTF 2015 guidelines with 2021 guidelines and 76.7 to 82.9% when comparing ADA 2003 guidelines with 2022 guidelines. Screening eligibility for prediabetes increased from 50.1 to 56.2% when comparing USPSTF 2015. with 2021 and from 89.4 – 93.7 percent when comparing ADA. 2003 to 2022. Screening eligibility for those with undiagnosed diabetes increased from 58.7 percent to 67.8 per cent when comparing USPSTF 2015 with 2022, but remained stable (97.6 percent to 99.1%) when comparing ADA 2003 to 2022 guidelines.

The authors write that the ADA 2022 guideline identifies a greater percentage of people with prediabetes/diabetes than the USPSTF 2021 guideline, but requires screening approximately twice the number of people.

2021 USPSTF lung cancer screening criteria expand eligibility

More information:
Abstract/Full Text (subscription or payment may be required)

Copyright © 2022 HealthDay. All rights reserved.

New guidelines would increase eligibility for diabetes screening (2022, May 18,)
Retrieved 19 May 20,22
from https://medicalxpress.com/news/2022-05-guidelines-diabetes-screening-eligibility.html

This document is subject of copyright. Except for fair dealings for private study or research purposes, there is no
Without permission, part may not be reproduced. The information is provided only for information purposes.

Source: medical xpress.

Leave a Reply

Your email address will not be published.

Back to top button